Haifeng Qiu, Ruixia Guo. "Penpulimab plus anlotinib as first-line treatment for persistent, recurrent, or metastatic cervical cancer: A multicentre, single-arm, phase II trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.19_suppl.211